Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites.
<h4>Background</h4>A malaria vaccine could be an important addition to current control strategies. We report the safety and vaccine efficacy (VE) of the RTS,S/AS01 vaccine during 18 mo following vaccination at 11 African sites with varying malaria transmission.<h4>Methods and findi...
Saved in:
| Main Author: | RTS,S Clinical Trials Partnership |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-07-01
|
| Series: | PLoS Medicine |
| Online Access: | https://doi.org/10.1371/journal.pmed.1001685 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: A review
by: Hassan Mumtaz, et al.
Published: (2023-06-01) -
Epitope specificity of antibody-mediated protection induced in mice by the malaria vaccine RTS,S/AS01
by: Yevel Flores-Garcia, et al.
Published: (2025-05-01) -
Safety of RTS,S/AS01E vaccine for malaria in African children aged 5 to 17 months: A systematic review and meta-analysis of randomized controlled trials
by: Joseph Alexis Zoa, et al.
Published: (2025-01-01) -
Safety of RTS,S/AS01E vaccine for malaria in African children aged 5 to 17 months: A systematic review and meta-analysis of randomized controlled trials.
by: Joseph Alexis Zoa, et al.
Published: (2025-01-01) -
Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S/AS01E vaccine, seasonal malaria chemoprevention and the combination of vaccination and chemoprevention
by: Ismaila Thera, et al.
Published: (2020-09-01)